Loading...
XASXAHC
Market cap66mUSD
Jan 07, Last price  
0.30AUD
1D
-3.91%
1Q
18.00%
Jan 2017
247.83%
Name

Austco Healthcare Ltd

Chart & Performance

D1W1MN
XASX:AHC chart
P/E
15.18
P/S
1.85
EPS
0.02
Div Yield, %
0.00%
Shrs. gr., 5y
5.59%
Rev. gr., 5y
12.90%
Revenues
58m
+38.53%
10,055,00021,988,00034,985,00047,531,00046,808,00043,021,00016,767,00018,197,00021,794,00031,308,00034,950,00032,028,00028,969,00028,971,00031,703,00031,598,00031,250,00035,882,00041,978,00058,153,000
Net income
7m
+213.37%
879,0002,205,0001,685,0002,164,000-8,945,000-9,681,000-11,050,000744,0001,040,0003,865,0001,093,000-3,651,000-6,417,0001,194,000637,0002,504,0003,424,0002,328,0002,258,0007,076,000
CFO
11m
+3,445.94%
00000000-384,000577,0001,870,000-2,212,000-2,552,0002,031,0001,420,0003,299,0003,208,0001,944,000320,00011,347,000
Dividend
Mar 02, 20230.0017 AUD/sh
Earnings
Feb 24, 2025

Profile

Austco Healthcare Limited, together with its subsidiaries, engages in the manufacture, distribution, marketing, supply, service, and sale of healthcare and electronic communications systems in Australia, New Zealand, Asia, Europe, and North America. It offers Tacera, an IP based nurse call solution for hospitals and aged care facilities. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020. Austco Healthcare Limited was founded in 1986 and is headquartered in Port Melbourne, Australia.
URL
https://austcohealthcare.com/
IPO date
Sep 24, 2004
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
58,153
38.53%
41,978
16.99%
35,882
14.82%
Cost of revenue
51,780
40,175
31,156
Unusual Expense (Income)
NOPBT
6,373
1,803
4,726
NOPBT Margin
10.96%
4.30%
13.17%
Operating Taxes
(1,426)
(443)
299
Tax Rate
6.33%
NOPAT
7,799
2,246
4,427
Net income
7,076
213.37%
2,258
-3.01%
2,328
-32.01%
Dividends
(897)
Dividend yield
1.81%
Proceeds from repurchase of equity
9,576
285
BB yield
-17.22%
-1.00%
Debt
Debt current
573
401
559
Long-term debt
2,903
246
1,350
Deferred revenue
(268)
Other long-term liabilities
6,062
92
36
Net debt
(10,080)
(4,874)
(6,814)
Cash flow
Cash from operating activities
11,347
320
1,944
CAPEX
(1,629)
(1,573)
(1,629)
Cash from investing activities
(11,063)
(1,573)
(1,629)
Cash from financing activities
8,840
(1,583)
(312)
FCF
6,688
(1,978)
1,766
Balance
Cash
13,556
4,673
7,628
Long term investments
848
1,095
Excess cash
10,648
3,422
6,929
Stockholders' equity
44,378
24,999
23,092
Invested Capital
41,570
22,129
16,604
ROIC
24.49%
11.60%
30.53%
ROCE
12.20%
7.05%
19.86%
EV
Common stock shares outstanding
308,996
291,487
285,071
Price
0.18
5.88%
0.17
70.00%
0.10
-20.00%
Market cap
55,619
12.24%
49,553
73.83%
28,507
-19.99%
EV
45,539
44,679
21,693
EBITDA
8,687
3,520
6,110
EV/EBITDA
5.24
12.69
3.55
Interest
149
68
52
Interest/NOPBT
2.34%
3.77%
1.10%